Buying APIs is not just about price and availability. For pharmaceutical companies, CDMOs,
distributors, and finished-dosage manufacturers, the real question is whether the material can be
used confidently in the intended market and application.
Before placing an order, buyers should first confirm the product name, CAS number, grade,
quantity, intended use, and target market. A product that is acceptable for one market or dosage
pathway may not automatically be suitable for another. That is why documentation review is an
important part of the buying process.
Key documents may include the Certificate of Analysis, SDS or MSDS, specifications, GMP
documentation, impurity profile, residual solvent information, stability data, and manufacturer
qualification documents. Depending on the product, buyers may also need to review regulatory
files such as DMFs, CEPs, ASMFs, or other market-specific support documents.
Batch-level information is equally important. Buyers should review the batch number,
manufacturing date, expiry or retest date, assay, purity, storage conditions, and any test results
relevant to the material.
At Ventalys, we help customers organize these details before supply execution. Our role is to
support pharmaceutical buyers with product availability, documentation coordination, batch
review, and practical commercial support so that materials can move through the supply chain
with greater confidence.
